RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans

J Neural Transm (Vienna) 108(10):1159-1166 · 2001 · PMID 11725818

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

77편 검색→75편 판독→55편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Butyrylcholinesterase K variant and Alzheimer disease Butyrylcholinesterase K variant and Alzheimer disease

출판 연도

1997: 1편119971998: 6편61999: 6편62000: 6편620002001: 2편22002: 1편12004: 1편12005: 5편520052006: 2편22007: 2편22008: 2편22009: 2편22010: 1편120102011: 1편12012: 1편12013: 3편32014: 1편12015: 2편220152016: 2편22017: 3편32018: 1편12019: 1편12020: 1편120202022: 1편12024: 1편12024

선별된 55편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01bche gene · activity19편

  1. 0.94

    Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K)

    Grubber JM, Saunders AM, Crane-Gatherum AR et al. · Neuroscience letters · 1999

  2. 0.94

    Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans 이 논문

    Kim KW, Jhoo JH, Lee JH et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2001

  3. 0.94

    Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages

    Ghebremedhin E, Thal DR, Schultz C et al. · Acta neuropathologica · 2007

  4. 0.93

    No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese

    Lee DW, Liu HC, Liu TY et al. · American journal of medical genetics · 2000

  5. 0.93

    Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population

    Simao-Silva DP, Bertolucci PHF, de Labio RW et al. · Chemico-biological interactions · 2013

  6. 0.93

    Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease

    Jasiecki J, Limon-Sztencel A, Zuk M et al. · Scientific reports · 2019

  7. 0.93

    Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains

    Ghebremedhin E, Thal DR, Schultz C et al. · Neuroscience letters · 2002

  8. 0.92

    Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain)

    Deniz-Naranjo MC, Munoz-Fernandez C, Alemany-Rodriguez MJ et al. · Neuroscience letters · 2007

  9. 0.92

    Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk

    Combarros O, Riancho JA, Infante J et al. · Dementia and geriatric cognitive disorders · 2005

  10. 0.91

    Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk

    Mateo I, Llorca J, Infante J et al. · European journal of neurology · 2008

  11. 0.90

    BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia

    Bizzarro A, Guglielmi V, Lomastro R et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2010

  12. 0.89

    Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population

    Bono GF, Simao-Silva DP, Batistela MS et al. · Neurochemistry international · 2015

  13. 0.87

    Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease

    Gok M, Madrer N, Zorbaz T et al. · Frontiers in molecular neuroscience · 2022

  14. 0.81

    Peripheral cholinergic disturbances in Alzheimer's disease

    Rakonczay Z, Horvath Z, Juhasz A et al. · Chemico-biological interactions · 2005

  15. 0.80

    Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study

    Cook LJ, Ho LW, Wang L et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2005

  16. 0.75

    Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?

    Josviak ND, Batistela MS, Souza RKM et al. · The International journal of neuroscience · 2017

  17. 0.64

    No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases

    Maetzler W, Keller S, Michelis J et al. · Neurobiology of disease · 2009

  18. 0.63

    The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme

    Altamirano CV, Bartels CF, Lockridge O · Journal of neurochemistry · 2000

  19. 0.60

    The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology

    Podoly E, Shalev DE, Shenhar-Tsarfaty S et al. · The Journal of biological chemistry · 2009

02epsilon4 allele · late-onset18편

  1. 0.96

    Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland

    McIlroy SP, Crawford VL, Dynan KB et al. · Journal of medical genetics · 2000

  2. 0.95

    Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease

    Raygani AV, Zahrai M, Soltanzadeh A et al. · Neuroscience letters · 2004

  3. 0.95

    No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease

    Singleton AB, Smith G, Gibson AM et al. · Human molecular genetics · 1998

  4. 0.95

    Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease

    Lehmann DJ, Johnston C, Smith AD · Human molecular genetics · 1997

  5. 0.95

    Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease

    Wiebusch H, Poirier J, Sevigny P et al. · Human genetics · 1999

  6. 0.95

    The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women

    Alvarez-Arcaya A, Combarros O, Llorca J et al. · Acta neurologica Scandinavica · 2000

  7. 0.95

    The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations

    Crawford F, Fallin D, Suo Z et al. · Neuroscience letters · 1998

  8. 0.95

    The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease

    Kehoe PG, Williams H, Holmans P et al. · Journal of medical genetics · 1998

  9. 0.94

    Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients

    Hiltunen M, Mannermaa A, Helisalmi S et al. · Neuroscience letters · 1998

  10. 0.94

    Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease

    Tilley L, Morgan K, Grainger J et al. · European journal of human genetics : EJHG · 1999

  11. 0.94

    Butyrycholinesterase K variant and Alzheimer's disease

    Panegyres PK, Mamotte CD, Vasikaran SD et al. · Journal of neurology · 1999

  12. 0.94

    Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease

    Lehmann DJ, Nagy Z, Litchfield S et al. · Human genetics · 2000

  13. 0.93

    Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease

    Yamamoto Y, Yasuda M, Mori E et al. · Journal of neurology, neurosurgery, and psychiatry · 1999

  14. 0.93

    Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease

    Brindle N, Song Y, Rogaeva E et al. · Human molecular genetics · 1998

  15. 0.93

    No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease

    Ki CS, Na DL, Kim JW et al. · American journal of medical genetics · 1999

  16. 0.90

    Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology

    Mattila KM, Rinne JO, Roytta M et al. · Journal of medical genetics · 2000

  17. 0.79

    Butyrylcholinesterase K variant and cerebral amyloid angiopathy

    Yamada M, Sodeyama N, Itoh Y et al. · Stroke · 1998

  18. 0.56

    Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups

    Lehmann DJ, Williams J, McBroom J et al. · Neuroscience · 2001

03cognitive · progression18편

  1. 0.95

    Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

    Lane R, Feldman HH, Meyer J et al. · Pharmacogenetics and genomics · 2008

  2. 0.95

    Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study

    Chuang YF, Varma V, An Y et al. · Journal of Alzheimer's disease : JAD · 2020

  3. 0.94

    Butyrylcholinesterase K and apolipoprotein epsilon4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease

    Yoo HB, Lee HW, Shin S et al. · Current Alzheimer research · 2014

  4. 0.94

    Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation

    Holmes C, Ballard C, Lehmann D et al. · Journal of neurology, neurosurgery, and psychiatry · 2005

  5. 0.94

    Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease

    Gabriel AJ, Almeida MR, Ribeiro MH et al. · Journal of Alzheimer's disease : JAD · 2018

  6. 0.93

    Onset of Alzheimer disease in apolipoprotein varepsilon4 carriers is earlier in butyrylcholinesterase K variant carriers

    Lane RM, Darreh-Shori T, Junge C et al. · BMC neurology · 2024

  7. 0.93

    Apolipoprotein epsilon4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease

    Darreh-Shori T, Siawesh M, Mousavi M et al. · Journal of Alzheimer's disease : JAD · 2012

  8. 0.92

    Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

    De Beaumont L, Pelleieux S, Lamarre-Theroux L et al. · Journal of Alzheimer's disease : JAD · 2016

  9. 0.92

    Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients

    Gabriel AJ, Almeida MR, Ribeiro MH et al. · Neuroscience letters · 2017

  10. 0.92

    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease

    Vijayaraghavan S, Darreh-Shori T, Rongve A et al. · Journal of Alzheimer's disease : JAD · 2016

  11. 0.91

    Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease

    Blesa R, Bullock R, He Y et al. · Pharmacogenetics and genomics · 2006

  12. 0.90

    The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients

    Ballard C, Morris C, Kalaria R et al. · Dementia and geriatric cognitive disorders · 2005

  13. 0.90

    Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease

    Darreh-Shori T, Vijayaraghavan S, Aeinehband S et al. · Neurobiology of aging · 2013

  14. 0.83

    Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease

    Bullock R, Bergman H, Touchon J et al. · Current medical research and opinion · 2006

  15. 0.82

    Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease

    Patterson CE, Todd SA, Passmore AP · The pharmacogenomics journal · 2011

  16. 0.80

    Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment

    Sokolow S, Li X, Chen L et al. · Journal of Alzheimer's disease : JAD · 2017

  17. 0.80

    Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease

    Han HJ, Kwon JC, Kim JE et al. · European neurology · 2015

  18. 0.79

    Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

    Lane RM, He Y · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013